Tibor Szarvas
Impact in
- Urology top 1%
- Urological Disorders and Treatments
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Protease and Inhibitor Mechanisms
Papers in
- Urology 24
- Urological Disorders and Treatments 21
-
- Protease and Inhibitor Mechanisms 14
- Co-authors
- H. RübbenHenning ReisF. vom DorpPéter NyírádyChristian NiedworokStephan TschirdewahnSüleyman ErgünAttila Szendrői
In The Last Decade
Tibor Szarvas
149 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Urology 308
- Cancer Research 618
- Surgery 936
- Oncology 503
- Pulmonary and Respiratory Medicine 575
Countries citing papers authored by Tibor Szarvas
This map shows the geographic impact of Tibor Szarvas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tibor Szarvas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tibor Szarvas more than expected).
Fields of papers citing papers by Tibor Szarvas
This network shows the impact of papers produced by Tibor Szarvas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tibor Szarvas. The network helps show where Tibor Szarvas may publish in the future.
Co-authors
The 25 scholars most cited alongside Tibor Szarvas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 7 | |
| 7 | 2021 | 7 | |
| 8 | 2020 | 11 | |
| 9 | 2020 | 8 | |
| 10 | 2020 | 29 | |
| 11 | 2020 | 0 | |
| 12 | 2019 | 2 | |
| 13 | 2017 | 13 | |
| 14 | 2016 | 6 | |
| 15 | 2015 | 19 | |
| 16 | 2015 | 5 | |
| 17 | 2013 | 2 | |
| 18 | 循環するアンジオスタチン,bFGFおよびTie2/TEKレベル並びに膀胱癌における予後へのそれらの影響 | 2012 | 2 |
| 19 | 2010 | 14 | |
| 20 | 2008 | 32 |
About Tibor Szarvas
Tibor Szarvas is a scholar working on Urology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 155 papers that have together received 2.3k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (62 papers), Urinary and Genital Oncology Studies (51 papers), Prostate Cancer Treatment and Research (30 papers), Urological Disorders and Treatments (21 papers), Peptidase Inhibition and Analysis (16 papers), Protease and Inhibitor Mechanisms (14 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). The work is most often cited by research in Urology (308 citations), Cancer Research (618 citations), Surgery (936 citations), Oncology (503 citations) and Pulmonary and Respiratory Medicine (575 citations). Tibor Szarvas has collaborated with scholars based in Germany, Hungary and Austria. Frequent co-authors include H. Rübben, Henning Reis, F. vom Dorp, Péter Nyírády, Christian Niedworok, Stephan Tschirdewahn, Süleyman Ergün, Attila Szendrői, Boris Hadaschik and Imre Romics. Their work appears in journals such as Urologic Oncology Seminars and Original Investigations, Pathology & Oncology Research, International Journal of Cancer, British Journal of Urology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.